1-3 of 3
Masayuki Ohkura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Naoto Takahashi, MD PhD, Itaru Matsumura, MD PhD, Shin Fujisawa, MD, Kenichi Ishizawa, MD PhD, Takaaki ONO, MD PhD, Emiko Sakaida, MD PhD, Naohiro Sekiguchi, MD PhD, Yusuke Tanetsugu, Kei Fukuhara, Masayuki Ohkura, Yuichiro Koide, Masayuki Hino, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4159.
https://doi.org/10.1182/blood-2019-121809
Published: 2019
Journal Articles

A Phase 2 Open-Label, Sequential-Cohort, Dose-Escalation Study of AMG 531 in Japanese Patients with Chronic Immune Thrombocytopenic Purpura (ITP).

Yukari Shirasugi, Kiyoshi Ando, Satoshi Hashino, Toshiro Nagasawa, Yoshiyuki Kurata, Yuji Kishimoto, Koji Iwato, Yusuke Sonehara, Masayuki Ohkura, Tomoko Ohtsu, Janet L. Nichol
Journal: Blood
Blood (2007) 110 (11): 1308.
https://doi.org/10.1182/blood.V110.11.1308.1308
Published: 2007
Journal Articles

Platelet Aggregation Analysis of AMG 531 in a Randomized, Placebo-Controlled Study in Healthy Japanese Subjects.

Yuji Kumagai, Tomoe Fujita, Machiko Ozaki, Kunihiko Sahashi, Masayuki Ohkura, Tomoko Ohtsu, Yoshihiro Arai, Yusuke Sonehara, Janet Nichol
Journal: Blood
Blood (2006) 108 (11): 1071.
https://doi.org/10.1182/blood.V108.11.1071.1071
Published: 2006